Madrigal Pharmaceuticals (MDGL) Leases (2019 - 2025)
Historic Leases for Madrigal Pharmaceuticals (MDGL) over the last 10 years, with Q3 2025 value amounting to $5.4 million.
- Madrigal Pharmaceuticals' Leases rose 11445.06% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 11445.06%. This contributed to the annual value of $2.4 million for FY2024, which is 4016.35% up from last year.
- Latest data reveals that Madrigal Pharmaceuticals reported Leases of $5.4 million as of Q3 2025, which was up 11445.06% from $5.9 million recorded in Q2 2025.
- In the past 5 years, Madrigal Pharmaceuticals' Leases ranged from a high of $5.9 million in Q2 2025 and a low of $411000.0 during Q2 2023
- Over the past 5 years, Madrigal Pharmaceuticals' median Leases value was $1.1 million (recorded in 2022), while the average stood at $1.7 million.
- Its Leases has fluctuated over the past 5 years, first tumbled by 6111.64% in 2023, then skyrocketed by 30260.99% in 2025.
- Quarter analysis of 5 years shows Madrigal Pharmaceuticals' Leases stood at $797000.0 in 2021, then decreased by 24.47% to $602000.0 in 2022, then skyrocketed by 184.55% to $1.7 million in 2023, then surged by 40.16% to $2.4 million in 2024, then surged by 124.36% to $5.4 million in 2025.
- Its last three reported values are $5.4 million in Q3 2025, $5.9 million for Q2 2025, and $2.1 million during Q1 2025.